Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Adjusting to daily life with social isolation and lockdown has its challenges and the dramatic situation that we find ourselves in because of the COVID-19 pandemic, means people with eating disorders are at risk of their disorder becoming more severe or relapsing.

COVID-19 has dramatically expanded across the world with a major outbreak in several countries. To limit the number of new cases and deaths, most governments have decided to put their countries on lockdown.

The increased risk to people with eating disorders at this time comes from multiple sources including:

  • Anxiety about infection
  • Changes in the availability of food
  • The effects of social isolation
  • More limited availability of adequate psychological and psychiatric treatments.

A potential practical solution to address some of these problems is to deliver enhanced cognitive behaviour therapy (CBT-E), an evidence-based treatment for all eating disorders, remotely.

 

The COVID-19 situation presents new challenges for people with eating disorders. As a clinician I see the devastating impact that the current threat, in combination with the policies currently in place to limit the spread of the virus, is having on people living with an eating disorder. We hope this new, practical guidance will support clinicians to offer an evidence-based treatment for patients during this difficult time. - Dr Rebecca Murphy, Senior Research Clinician, Department of Psychiatry, University of Oxford.

 

In this new guidance document - Challenges and Opportunities for CBT - E in light of COVID-19 several issues are discussed including:

  • The challenges and advantages of delivering CBT-E remotely
  • New problems that patients with eating disorders may face in this period which need addressing
  • Potential opportunities for improving the outcome of treatment
  • How to adapt the various stages, strategies and procedures of CBT-E for teletherapy use in the particular circumstances of COVID-19.

View this new practical guidance for therapists.

 

 

More information from The Centre for Research on Eating Disorders at Oxford (CREDO).

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

What is the Role of Science in Mental Health?

A new summary report, What science has shown can help young people with anxiety and depression - Identifying and reviewing the 'active ingredients' of effective interventions, from Wellcome has been published. It includes new research from Oxford University, which investigates the knowns and unknowns of SSRI treatment (antidepressant drugs) in young people with depression and anxiety.

New Research Presented at the ECNP Conference - October 2021

Dr Angharad de Cates and Dr Liliana Capitão were just two of the department's researchers presenting and publishing new research at the European College of Neuropsychopharmacology (ECNP) Conference 2021, in Lisbon.

Researchers Address Mental Health Effects of the Pandemic on Young People

In a new policy briefing, a team of researchers at King’s College London and Oxford University highlight the multiple effects that the COVID-19 pandemic has had on children and young people in the UK through their education and daily life, including challenges around social isolation, academic pressures, adjusting to online learning and coping with reopening of schools.

Turing Fellowships for Over 30 Oxford Academics

Professor John Geddes, WA Handley-elect Chair of Psychiatry, is one of the thirty-three University of Oxford researchers, which have been named Turing Fellows for the 2021/22 academic year.

Simple Intervention Effectively Treats Depression During COVID 19

New research shows that even a very simple intervention, administered by non-specialists with just 15 hours of training, can effectively treat depression during COVID-19.

Over a Third of COVID-19 Patients Diagnosed with at Least One Long-COVID Symptom

A new study from the University of Oxford and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC) investigated long-COVID in over 270,000 people recovering from COVID-19 infection, using data from the US-based TriNetX electronic health record network.